The Role of Microglia and T Cells in Age-Associated Decline
A recent study by Janos Groh and colleagues in Mikael Simons’ group at the Institute of Neuronal Cell Biology, Technical
Read more
CNS
Evaluating Photoreceptor Replacement as a Viable Therapy in a Late-Stage LCA Mouse Model
Retinal degeneration represents a primary cause of irreversible blindness, with both its onset and severity differing significantly among various conditions.
Read more
Sanofi Bolsters Alzheimer’s Disease Pipeline with $470M Acquisition of Vigil Neuroscience
Sanofi has announced a definitive agreement to acquire clinical-stage biotech firm Vigil Neuroscience, Inc., in a move to expand its
Read more
Microglia Demyelination Shields CNS from Axonal Damage
A groundbreaking study by Groh et al., recently featured in Nature Communications, delves into the interplay between adaptive immunity and
Read more
Sangamo and Genentech to Develop Genomic Medicines for Neurodegenerative Diseases
Sangamo Therapeutics Enters License Agreement with Genentech to Develop Genomic Medicines for Neurodegenerative Diseases Sangamo Therapeutics, Inc., a leader in
Read more
Ventus’ NLRP3 Inhibitor Shows Potential for CNS Diseases in Phase 1 Trial
Ventus Therapeutics, a US-based clinical-stage biopharmaceutical company leveraging its exclusive structural biology and computational chemistry platform, ReSOLVE™, has disclosed promising
Read more
3DProSeed Hydrogel Plate – Cancer Research and CNS Applications
3DProSeed Hydrogel Plate – Application Data – Cancer Research and CNS A Ectica Technologies Case Study The 3DProSeed Hydrogel Plate developed
Read more